Skip to main content

  • First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study

    • Posted: 11/01/2021
    • Author:

      Jose M. de la Torre Hernandez, Imanol Otaegui, Asier Subinas, Antonio Gomez-Menchero, Raul Moreno, Juan Rondan, Erika Muñoz-Garcia, Fermin Sainz-Laso, Bruno Garcia del Blanco, Jose R. Rumoroso, Jose F. Diaz, Alberto Berenguer, Josep Gomez-Lara and Javier Zueco

    • 2021CRM

    Abstract

    Objectives

    We sought to investigate stent healing and neointimal hyperplasia with ihtDEStiny drug-eluting stent (DES) by optical coherence tomography (OCT) examination conducted 9 months after implantation.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details